Skip to content
naulon
Get started
Not checkedNot checked for notices yet.

Cannabidiol as a potential new type of an antipsychotic. A critical review of the evidence

Cathrin Rohleder, Juliane K. Mueller, Bettina Lange and 1 more

Frontiers in Pharmacology · 2016

doi:10.3389/fphar.2016.00422 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

References118

  1. 59.

    Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia · 2006

  2. 89.

    NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia · 2013

116 more references, whose wording the paper’s licence keeps private.

Cited by papers we hold1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.